Načítá se...
Formulation and characterization of EGCG for the treatment of superficial bladder cancer
In the United States, the annual incidence of bladder cancer is approximately 70,000 new cases, with a mortality rate of approximately 15,000/year. The most common subtype (70%) of bladder cancer is superficial, namely hte non-muscle invasive disease form limited to the urothelium. The rate of progr...
Uloženo v:
| Vydáno v: | Int J Mol Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
D.A. Spandidos
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5504970/ https://ncbi.nlm.nih.gov/pubmed/28627636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2017.3024 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|